Insulin efsitora alfa, formerly known as basal insulin Fc, or BIF, is a fusion protein that combines insulin with a human immunoglobulin G Fc domain, achieving sustained release over a time period suitable for once-weekly dosing.
06-06-2024 | Diabetes | Clinical Trial Summary | Article